Mashup Score:9
HealioMinimally invasive hysterectomy yields worse outcomes than open surgery in cervical cancer - 1 week
Mashup Score:9
Mashup Score:9
HealioMinimally invasive hysterectomy yields worse outcomes than open surgery in cervical cancer - 1 week
Mashup Score:9
Mashup Score:9
www5.shocklogic.comEHA-EBMT 5th European CAR T-Cell Meeting - 4 days
Mashup Score:9
Page 1 of 4 – Personal Details ONLINE REGISTRATION Before you start your registration, please note: You need to complete all steps at once to...
#CART23 is just a few weeks away and we're looking forward to speaking with leading experts in #CART who will bring you the latest in the field! Register now: ✍️ https://t.co/gjO0wiqDCf @TheEBMT @EHA_Hematology #HemOnc #ImmunoOnc #CARTcell #tcellrx #MMsm #LymSM #LeuSM https://t.co/gjO0wiqDCf - view on twitter
Mashup Score:6
www5.shocklogic.comEHA-EBMT 5th European CAR T-Cell Meeting - 1 week
Mashup Score:6
Page 1 of 4 – Personal Details ONLINE REGISTRATION Before you start your registration, please note: You need to complete all steps at once to...
#CART23 - We're looking forward to the EBMT-EHA 5th European CAR T-cell Meeting being held in Rotterdam on 9-11 February! To register for this year's meeting, click here: https://t.co/obzAVO3Z0m @TheEBMT @EHA_Hematology #HemOnc #ImmunoOnc #CARTcell #tcellrx #MMsm #LymSM #LeuSM https://t.co/obzAVO3Z0m - view on twitter
Mashup Score:4
VJHemOncGenomic testing and clinical decision making in CLL - 4 days
Mashup Score:4
Learn more about the importance of genomic testing in CLL and how this influences clinical decision making with expert-led...
📣 Want to learn more about the importance of genomic testing in CLL & its role in clinical decision making? We have all you need in our exclusive feature with expert insights: ➡️ https://t.co/OI1Hi7bVqi ⬅️ #CLLsm #LeuSM #HemOnc https://t.co/OI1Hi7bVqi - view on twitter
Mashup Score:3
VJHemOncZanubrutinib was approved by the Food and Drug Administration (FDA) on the 19th of January 2023, for the treatment...
🚨 Zanubrutinib was approved on January 19th for patients with CLL/SLL. Check out our latest feature to read more details: 👉https://t.co/YmEivx4sMg👈 @ASH_hematology #ASH22 #Leusm #CLLsm #HemOnc #Leukemia - view on twitter
Mashup Score:3
VJHemOncAddressing cardiotoxicity concerns with the use of gilteritinib - 5 days
Mashup Score:3
Eunice Wang, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, comments on the importance of managing the potential cardiotoxicity...
Find out more about the importance of addressing potential cardiotoxicity concerns with the use of gilteritinib in AML in our exclusive interview with @EuniceWangMD of @RoswellPark: ➡️ https://t.co/R82w0RdrIl #ASH22 #LeuSM #AMLsm #HemOnc - view on twitter
Mashup Score:3
VJHemOncReal-world safety analysis of deferiprone in patients with MDS - 5 days
Mashup Score:3
Amer Zeidan, MBBS, Yale University and Yale Cancer Center, New Haven, CT, discusses challenges with iron chelation therapy in...
🎥 @Dr_AmerZeidan shares some insights into a real-world analysis which investigated the safety of deferiprone in patients with MDS. Watch his interview here: 👉https://t.co/H6SNjDHbFJ👈 @ASH_hematology #ASH22 #MDSsm #HemOnc - view on twitter
Mashup Score:3
HealioMark Lewis, MD, discusses career motivation, Twitter and oncology’s emotional ‘yin-yang’ - 1 week
Mashup Score:3
Mark A. Lewis, MD, has two special drawers in his office desk — one with notes of appreciation he has received from patients over...
.@marklewismd discusses career motivation, Twitter and oncology’s emotional ‘yin-yang’ https://t.co/XUsU2dsWzL #HemOnc #OncAlert #MedEd - view on twitter
Mashup Score:2
VJHemOncT-cell lymphoma highlights at ASH 2022: Unmet needs, clinical trial updates & future outlooks - 1 week
Mashup Score:2
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans,...
🚨 We're pleased to bring you another weekly podcast! This week, you'll hear from experts @CwynKate & @DrSwami_Iyer who share key highlights in T-cell lymphoma at #ASH22! Listen here: 🎧 https://t.co/mrPL6zfeVR #LymSM #HemOnc #TcellLymphoma https://t.co/mrPL6zfeVR - view on twitter
Mashup Score:2
HealioLong-course chemoradiation may improve organ preservation rates in rectal cancer - 3 days
Mashup Score:2
A long course of chemoradiation therapy appeared associated with higher organ preservation rates vs. a short course among a cohort of patients with rectal...
Long-course chemoradiation may improve organ preservation rates in rectal cancer. https://t.co/sGpX979FRa @ASCO #GI23 #HemOnc #OncAlert #MedEd #RectalCancer #NeoadjuvantTherapy @MSKCancerCenter - view on twitter
Minimally invasive surgery conferred lower survival rates than open surgery among women with cervical cancer, according to randomized phase 3 trial results presented at...
#CervicalCancerAwarenessMonth Minimally invasive surgery conferred lower survival rates than open surgery among women with cervical cancer, phase 3 trial results showed. https://t.co/dCVKKW8pRe #CervicalCancer #Cancer #HemOnc #OncAlert #MedEd #SGOmtg @SGO_org - view on twitter